First steps of human coronavirus NL63 (HCoV-NL63) infection were previously 27 described. The virus binds to target cells by heparan sulfate proteoglycans, and interacts with 28 the ACE2 protein. Subsequent events, including virus internalization and trafficking, remain 29 to be elucidated. In this study, we mapped the process of HCoV-NL63 entry into LLC-Mk2 30 cell line and ex vivo 3D tracheobronchial tissue. 31 Using a variety of techniques we have shown that HCoV-NL63 virions require 32 endocytosis for successful entry to the LLC-MK2 cells, and interaction between the virus and 33 the ACE2 molecule triggers recruitment of clathrin. Subsequent vesicle scission by dynamin 34 results in virus internalization, and the newly formed vesicle passes the actin cortex, what 35 requires active cytoskeleton rearrangement. Finally, acidification of the endosomal 36 microenvironment is required for successful fusion and release of viral genome into the 37 cytoplasm. Also for 3D tracheobronchial tissue cultures we observed that the virus enters the 38 cell by clathrin-mediated endocytosis, but obtained results suggest that this pathway may be 39 bypassed. 40 41 Importance 42
Introduction
Immunostaining showed that the virus particles bound to the ACE2 start to co-localize with 143 clathrin (Manders'coeff. = 0.849, n = 6) ( Fig. 2C) , while there is no co-localization between 144 non-ACE2-bound virions and clathrin (Manders'coeff. = 0.189, n = 6).
146
HCoV-NL63 co-localizes with clathrin during entry 147 To determine whether co-localization with clathrin following the ACE2 binding is 148 relevant, and indeed the virus enters the cell by clathrin-coated pits we analyzed 149 co-localization of intracellular virions with clathrin. Briefly, LLC-Mk2 cells were incubated at 150 32C for 5-20 min with gradient-purified HCoV-NL63, fixed, immunostained and analyzed 151 with confocal microscopy. Results showed co-localization of virions entering the cell with 152 clathrin (Manders'coeff. = 0.584; n = 7) ( Fig. 3A) , whereas no co-localization with caveolin-1 153 was observed (Manders' coeff. = 0.053; n = 5) ( Fig. 3B) . HCoV-NL63 co-localization with 154 clathrin and caveolin was also studied in HAE model. For this, cultures were incubated with 155 gradient-purified HCoV-NL63 at 32C for 2 h; the virus and the cellular proteins were 156 immunostained and analyzed with confocal microscopy. HCoV-NL63 virions also in this these compounds was verified with the positive control (fluorescently-labelled transferrin) 168 (26, 27) . LLC-Mk2 cells were treated with Pitstop 2, MitMAB or control DMSO for 30 min 169 at 37C, following transferrin uptake for 45 min at 37C. Confocal images showed that both 170 inhibitors blocked transferrin endocytosis, as the protein was present only on the cell surface 171 ( Fig. 4A-D) . 172 Subsequently, LLC-Mk2 cells were incubated with one of the inhibitors at 37C for 173 30 min and inoculated with gradient-purified HCoV-NL63 at 32C for 5 min. Following 174 immunostaining of the HCoV-NL63 N protein and actin, virus endocytosis was analyzed 175 using confocal microscopy. Results showed that virus internalization was hampered in cells 176 pre-treated with clathrin and dynamin inhibitors, as compared to the DMSO-treated cells 177 ( Fig. 4D-G) . Simultaneously, a cytotoxicity test of the entry inhibitors was performed, which 178 showed no toxic effect of the tested compounds to LLC-Mk2 cells (Fig. 5) . In order to ensure 179 that our observations are not biased, statistical analysis of virus entry was performed. For this, 180 an algorithm was prepared for image analysis and 3D representation of the cell was prepared 181 and virus position in the cell was determined (Fig. 6) . 182 Similar experiment was conducted using HAE cultures. For this, cultures were 183 incubated for 1 h at 37C with inhibitors described above, following incubation with gradient-184 purified HCoV-NL63 at 32º C for 2 h. A strong inhibition of virus internalization in cultures 185 pre-incubated with clathrin or dynamin inhibitors was observed, compared to control cells 186 ( Fig. 7) . No cytotoxicity to HAE was observed for the tested inhibitors after 3 h incubation at 187 37C ( Fig. 8) .
189
Clathrin mediated endocytosis is the main entry route for HCoV-NL63 190 Even though certain cargo is usually internalized by a single route, frequently other 191 pathways may be used as alternatives. We therefore aimed to test whether inhibition of clathrin-mediated entry with chemical inhibitors results in inhibition of virus replication. To 193 address this, we incubated LLC-Mk2 cells with a given inhibitor at 37º C for 1 h and infected 194 them with HCoV-NL63 (TCID 50 = 400 per ml) for 2 h at 32C. Subsequently media were 195 removed and cells were washed thrice with acidic buffer, following washing with 1 × PBS 196 (pH 7.4). Next, cells were overlaid with culture medium containing a given inhibitor and 197 incubated at 32°C for 4 days. Cells were fixed and immunostained for HCoV-NL63 N protein 198 to assess the number of infected cells. To assess the non-specific effect of entry inhibitors, 199 control cells were treated with these also 4 h p.i. Clearly, in the presence of clathrin-mediated 200 endocytosis inhibitors (Pitstop 2 and MitMAB) the number of HCoV-NL63-infected cells was 201 much lower compared to the control. However, MitMAB also inhibited virus replication at 202 later stages of the infection (Fig. 9) . To ensure that entry inhibitors affected HCoV-NL63 203 infection in LLC-Mk2 cells, we analyzed by RT-qPCR virus replication at 120 h p.i. in the 204 presence of tested compounds. The analysis showed a ~2-log decrease in virus progeny 205 production in the presence of Pitstop 2 and MitMAB, compared to DMSO-treated cells and a 206 slight increase of RNA copy levels in the presence of nystatin (Fig 10A) . Importantly, no 207 cytotoxic effect was observed for the tested inhibitors applied to LLC-Mk2 for 4 days at 32°C 208 (Fig 10B) . The influence of tested inhibitors on HCoV-NL63 infection was analyzed also in 209 HAE cultures. For this, cultures were pre-incubated with a given inhibitor (Pitstop 2, 210 MitMAB, nystatin or control DMSO) for 1 h at 37°C and infected with HCoV-NL63 at 211 TCID 50 of 400 per ml for 2 h at 32°C. Subsequently, non-internalized virions were inactivated 212 by acid wash, cultures were washed with 1 × PBS, and incubated with a given inhibitor for 10 213 min. After that time supernatants were discarded and cultures were incubated for 5 days at 214 32°C. During this period, cultures were incubated with a given inhibitor for 10 min at 32°C 215 every 24 h. Viral RNA from these samples was quantified by RT-qPCR. Virus replication in 216 HAE was not affected by any of the tested inhibitors ( Fig. 10A ).
Page 10 218 TMPRSS2 is important during early stages of the infection 219 It was previously suggested that coronaviruses may bypass the endocytic entry route 220 employing TMPRSS2 protease, which primes the fusion protein and enable fusion of viral 221 and cellular membranes on the cell surface (31, 32) . We have tested whether inhibition of the 222 TMPRSS2 proteases with camostat affects the HCoV-NL63 infection. We observed that 223 inhibition of TMPRSS2 protease hampers virus infection in HAE cultures, while it has no 224 effect on virus replication in LLC-MK2 cells (Fig. 11A) . No inhibition of virus entry was 225 observed in any of the models, as tracked with confocal microscopy, visualizing the 226 nucleoprotein ( Fig. 11B) . As only single entry events per view were observed, several images 227 for camostat-treated and control cells are presented. In total, 500 entry events into HAE cells 228 were tracked and no difference between the camostat-treated sample and control sample was 229 noted.
231
HCoV-NL63 entry requires actin re-modelling 232 We studied trafficking of HCoV-NL63 inside the cell. As entry by endocytosis would 233 probably require re-modelling of the cytoskeleton, we evaluated virus internalization in the 234 presence of cytochalasin D, jasplankinolide or nocodazole. The first chemical inhibits actin 235 polymerization, whereas the second binds F-actin and stabilizes actin filaments (33, 34) . The 236 last compound interferes with the microtubule formation. The analysis showed that actin 237 inhibitors prevented virus particles from penetrating the cell, with visible viral particles 238 accumulation on actin cortex or unstructured actin deposits. Microtubule inhibitor did not 239 affect virus entry ( Fig. 12) . No cytotoxicity was observed for the tested inhibitors ( Fig. 13 ).
Discussion

241
Previously, we and others described the first steps of the HCoV-NL63 infection process, 242 showing that it begins with the virus binding to the cellular membrane via heparan sulfate 243 proteoglycans, which then enable/facilitate interaction with the entry receptor, ACE2 (14, 18, 244 19) . Little is known about the subsequent virus internalization and its trafficking through the 245 cytoplasm, and some published data are contradictory. For example, the role played by 246 cathepsins and acidification of the microenvironment during transition of the HCoV-NL63 S 247 protein to its fusogenic form remains unclear. 248 We made an effort to systematically examine every step of the process. First, we tested 249 whether the virus requires endocytosis for successful entry. To do this, we carried out It is noteworthy that we were not able to block virus infection of HAE cultures using 281 inhibitors of endocytosis. This may be related to the fact that the cultures were exposed to 282 inhibitors for a very short time during apical washes, which is not sufficient to permanently 283 block the infection. On the other side, it is also possible that in HAE HCoV-NL63 is able to 284 enter the cell by an alternative route. Recent reports on other coronaviruses (31, 32, 38) 285 suggested that these viruses may bypass the endocytic entry route using TMPRRS2 as the 286 priming protease, enabling the entry directly from the cell surface. Our experiments showed 
Virus preparation and titration 340
The HCoV-NL63 stock (isolate Amsterdam 1) was generated by infecting monolayers 341 of LLC-Mk2 cells. The virus-containing liquid was aliquoted and stored at −80°C. A control 342 LLC-Mk2 cell lysate from mock-infected cells was prepared in the same manner. The virus 343 yield was assessed by titration on fully confluent LLC-Mk2 cells in 96-well plates, according 344 to the method described by Reed and Muench (40) . 359 LLC-Mk2 cells were seeded on coverslips in six-wells plates (TPP) and cultured for 360 2 days at 37°C. Subsequently, cells were incubated with a given inhibitor for 30 min at 37°C, 361 and later with 50 μl of purified HCoV-NL63 or mock sample for 1 h at 32°C. For the ex vivo 362 experiment, HAE cultures were exposed to the tested inhibitor or control PBS for 1 h at 37°C, 363 following inoculation with iodixanol-concentrated HCoV-NL63 or mock sample. Following 364 2 h incubation at 32°C, unbound virions were removed by washing with 1 × PBS. Cells were 365 then washed with 1 × PBS and fixed with 4% paraformaldehyde (PFA).
Inhibition of virus entry
366
Transferrin and albumin were used as positive controls, as they were previously 367 described to serve as a cargo in the clathrin-and caveolin-dependent endocytosis, 368 respectively (41, 42). LLC-Mk2 cells were seeded on coverslips in six-wells plates (TPP, 369 Switzerland) and cultured for 2 days at 37°C. Subsequently, cells were incubated with a given 370 inhibitor for 30 min at 37°C, following incubation with Alexa Fluor 488-labeled transferrin 371 (100 μg/ml; Molecular Probes) or FITC labeled albumin (500 μg/ml; Sigma-Aldrich, Poland) 372 or control PBS for 45 min at 32°C. Cells were then washed with 1 × PBS and fixed in 373 4% PFA. gradient-purified HCoV-NL63 for 40 min at 4C, following 120 min incubation at 32C.
509
HCoV-NL63 co-localization with clathrin (A) or caveolin (B) was analyzed with confocal 510 microscopy (HCoV-NL63: green, clathrin and caveolin: red, nuclei: blue). Cells incubated 511 with mock and stained with isotypic antibodies were used as control (C). Scale bar = 5 m. 
